NIH

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)

Funding Opportunity PAR-18-802 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the US. Specifically, the FOA solicits encourages grant applications from SBCs to develop or adapt, apply, and validate existing or emerging technologies into user-friendly products for cancer prevention, diagnosis, or treatment in low-resource settings. These technologies should be practical and affordable in the low-resource settings, including remote or underserved populations within or outside the US. The technologies may include, but are not limited to tools for vaccine dissemination/delivery, imaging, in vitro diagnosis, or treatment of pre-cancerous (pre-neoplastic) or cancerous lesions that are preventable or treatable within low-resource settings. Strong emphasis is placed on technologies that directly provide or immediately lead to treatment options available in the local health system.
Categories: NIH

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)

Funding Opportunity PAR-18-801 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the US. Specifically, the FOA solicits encourages grant applications from SBCs to develop or adapt, apply, and validate existing or emerging technologies into user-friendly products for cancer prevention, diagnosis, or treatment in low-resource settings. These technologies should be practical and affordable in the low-resource settings, including remote or underserved populations within or outside the US. The technologies may include, but are not limited to tools for vaccine dissemination/delivery, imaging, in vitro diagnosis, or treatment of pre-cancerous (pre-neoplastic) or cancerous lesions that are preventable or treatable within low-resource settings. Strong emphasis is placed on technologies that directly provide or immediately lead to treatment options available in the local health system.
Categories: NIH

NIOSH Exploratory/Developmental Grant Program (R21)

Funding Opportunity PAR-18-798 from the NIH Guide for Grants and Contracts. The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. NIOSH sponsors exploratory and developmental research projects by providing support for the early and conceptual stages of projects. Applicants must concisely describe the occupational health burden(s) being addressed in their proposal while also linking the need for the proposed research activities to planned outputs that will help address or alleviate this burden. Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.
Categories: NIH

K01 Mentored Research Scientist Development Award

Funding Opportunity PAR-18-799 from the NIH Guide for Grants and Contracts. The purpose of the K01 grant program is to provide support and dedicated time for a supervised (mentored) career development experience in occupational safety and health research, leading to research independence. This grant program also is to help ensure the availability of adequate numbers of highly trained scientists and educators to address critical issues in occupational safety and health.
Categories: NIH

NIOSH Small Research Grant Program

Funding Opportunity PAR-18-797 from the NIH Guide for Grants and Contracts. The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, to explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The NIOSH R03 grant mechanism supports small occupational safety and health research projects that can be carried out with limited resources such as pilot and feasibility studies, secondary data analysis or development of research methods.
Categories: NIH

Notice for the All of Us Research Program Genome Centers (OT2) Funding Announcement and Informational Webinar

Notice NOT-PM-18-003 from the NIH Guide for Grants and Contracts
Categories: NIH

Biomarkers Discovery In Parkinsonism (U01 Clinical Trial Optional)

Funding Opportunity PAR-18-800 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support hypothesis-driven research to discover human biomarkers in Parkinsons disease and other Parkinsonian syndromes, as a component of the NINDS Parkinsons Disease Biomarkers Program (PDBP). This FOA encourages biomarkers discovery projects in 1) genetically causal Parkinson's disease, especially for particular sub-types of Parkinson's Disease (PD), including genetic cohorts, biologically defined cohorts of idiopathic PD, or ethnic subgroups of idiopathic PD; 2) The differentiation of synucleinopathies (such as PD and Multiple System Atrophy (MSA) from tauopathies (such as Progressive Supranuclear Palsy and Corticobasal degeneration); or 3) to improve diagnostic differentiation between idiopathic/subtypes of PD and these disorders, as well as from Essential tremor. In order to further advance research in this area, broad sharing of biospecimens and associated data is a critical feature of the PDBP generally and of this FOA specifically. A timeline including milestones, which will be used to evaluate the application not only in peer review but also in consideration of the awarded project for funding of non-competing award years, is required for all studies.
Categories: NIH

NIH Directors Transformative Research Award (R01 - Clinical Trial Optional)

Funding Opportunity RFA-RM-18-009 from the NIH Guide for Grants and Contracts. The NIH Director's Transformative Research Award supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Applications from individuals with diverse backgrounds and in any topic relevant to the broad mission of NIH are welcome. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research. The NIH Directors Transformative Research Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.
Categories: NIH

Findings of Research Misconduct

Notice NOT-OD-18-186 from the NIH Guide for Grants and Contracts
Categories: NIH

NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional)

Funding Opportunity RFA-RM-18-008 from the NIH Guide for Grants and Contracts. The NIH Directors New Innovator Award supports early stage investigators of exceptional creativity who propose highly innovative new research approaches with the potential to produce a major impact on broad, important problems in biomedical or behavioral research. Applications from individuals with diverse backgrounds and in any topic relevant to the broad mission of NIH are welcome. The NIH Director's New Innovator Award complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The NIH Directors New Innovator Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.
Categories: NIH

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

Funding Opportunity PAR-18-796 from the NIH Guide for Grants and Contracts. NLM wishes to accelerate the availability of and access to secure, complete data sets and computational models that can serve as the basis of transformative biomedical discoveries by improving the speed and scope of the curation processes.
Categories: NIH

Working with Human Subjects? New Human Subjects System Replaces NIH’s Inclusion Management System

NIH Extramural Research & Funding News - May 21, 2018 - 4:26pm

As of June 9, 2018, a new Human Subjects System will replace the Inclusion Management System (IMS) currently used for reporting participant sex/gender, race, and ethnicity information for NIH grants. The new system consolidates human subject information submitted in applications and progress reports and will be used for all human subject-related post-submission updates as of its release on June 9.

Recipients will be able to access the system through the Human Subject link that will be on both the eRA Commons Status page and in the RPPR. Investigators and signing officials will be able to make study updates or corrections (including just-in-time or off-cycle updates) through the new system.

Be prepared! Complete any in-progress enrollment records to ensure their migration to the new system. Records that have not been submitted by June 8, 2018 will not be available in the Human Subjects System and will need to be re-entered.

The new system also supports submission of participant-level sex/gender, race, ethnicity and age data using a CSV file to populate the Inclusion Enrollment Report.

Learn more about the transition to the Human Subjects System by reading the guide notice, checking out the website, or by watching a video or viewing other resources on our system training page.

Categories: NIH

Now Available: Delegate Tasks When Working on Interim or Final RPPRs

NIH Extramural Research & Funding News - May 21, 2018 - 2:36pm

The interim Research Performance Progress Report (I-RPPR) and final RPPR (F-RPPR) are submitted online through eRA Commons in the same format as the annual RPPR.  We’ve often been asked if working on I-RPPR and/or F-RPPR be delegated to an Assistant (ASST) role. We are happy to announce that, yes, it is now possible to delegate working on I-RPPR and F-RPPR to anyone with the Assistant (ASST) role.

 

Read more in the eRA Items of Interest.  Want more updates on NIH electronic submission and eRA Commons straight to your mailbox? Subscribe today!

Categories: NIH

AHRQ Small Research Grant Program (R03)

Funding Opportunity PA-18-794 from the NIH Guide for Grants and Contracts. This FOA encourages Small Research Grant (R03) applications, and expresses AHRQ priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Categories: NIH

AHRQ Health Services Research Demonstration and Dissemination Grants (R18)

Funding Opportunity PA-18-793 from the NIH Guide for Grants and Contracts. The Research Demonstration and Dissemination Grant (R18) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R18 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ.
Categories: NIH

AHRQ Health Services Research Projects (R01)

Funding Opportunity PA-18-795 from the NIH Guide for Grants and Contracts. The Research Project Grant (R01) is an award made by AHRQ to an institution/organization to support a discrete, specified health services research project. The project will be performed by the named investigator and study team. The R01 research plan proposed by the applicant institution/organization must be related to the mission and priority research interests of AHRQ
Categories: NIH
Syndicate content